Creo Medical Group PLC (CREO)

London
Currency in GBP
18.50
+0.25(+1.37%)
Closed
CREO Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Day's Range
17.5018.50
52 wk Range
12.0044.00
Key Statistics
Edit
Bid/Ask
17.00 / 19.00
Prev. Close
18.25
Open
18.25
Day's Range
17.5-18.5
52 wk Range
12-44
Volume
90.66K
Average Volume (3m)
892.66K
1-Year Change
-58.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CREO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
57.50
Upside
+210.81%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Creo Medical Company Profile

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; SlypSeal Flex, an electrosurgical haemostasis device; and SpydrBlade Flex, a bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the gastrointestinal (GI) tract; ScopeClip for clip placement in the digestive tract; ScopeInject for endoscopic injection into GI mucosa; ScoprGrasp, a disposable grasping forceps for digestive and bronchial endoscopy; ScopeBite, a portfolio of digestive biopsy forceps; and other products for gastroenterology, pulmonology, and urology. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, the United Kingdom.

Compare CREO to Peers and Sector

Metrics to compare
CREO
Peers
Sector
Relationship
P/E Ratio
−3.3x−1.2x−0.6x
PEG Ratio
−0.070.010.00
Price/Book
1.6x1.1x2.6x
Price / LTM Sales
2.5x2.6x3.1x
Upside (Analyst Target)
210.8%117.5%55.4%
Fair Value Upside
Unlock26.6%10.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 57.50

(+210.81% Upside)

Earnings

Latest Release
May 22, 2023
EPS / Forecast
-0.07 / --
Revenue / Forecast
13.53M / 13.90M
EPS Revisions
Last 90 days

People Also Watch

3.95
ANIC
-1.25%
254.80
DLGD
+0.24%
1,293.50
GSK
-2.82%

FAQ

What Is the Creo Medical (CREO) Stock Price Today?

The Creo Medical stock price today is 18.50

What Stock Exchange Does Creo Medical Trade On?

Creo Medical is listed and trades on the London stock exchange.

What Is the Stock Symbol for Creo Medical?

The stock symbol for Creo Medical is "CREO."

What Is the Creo Medical Market Cap?

As of today, Creo Medical market cap is 74.40M.

What is Creo Medical Earnings Per Share?

The Creo Medical EPS is -0.062.

From a Technical Analysis Perspective, Is CREO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.